Volume 180, Issue 3 pp. 621-630
Paediatric Dermatology

A minimally invasive tool to study immune response and skin barrier in children with atopic dermatitis

L. Hulshof

L. Hulshof

Emma Children's Hospital Amsterdam UMC, University of Amsterdam, Department of Paediatric Respiratory Medicine and Allergy, Amsterdam, the Netherlands

Search for more papers by this author
D.P. Hack

D.P. Hack

Department of Dermatology, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands

Search for more papers by this author
Q.C.J. Hasnoe

Q.C.J. Hasnoe

Coronel Institute of Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands

Search for more papers by this author
B. Dontje

B. Dontje

Emma Children's Hospital Amsterdam UMC, University of Amsterdam, Department of Paediatric Respiratory Medicine and Allergy, Amsterdam, the Netherlands

Search for more papers by this author
I. Jakasa

I. Jakasa

Department of Chemistry and Biochemistry, Laboratory for Analytical Chemistry, Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb, Croatia

Search for more papers by this author
C. Riethmüller

C. Riethmüller

Serend-ip GmbH, Munster, Germany

Search for more papers by this author
W.H.I. McLean

W.H.I. McLean

Centre for Dermatology and Genetic Medicine, Division of Molecular Medicine, Colleges of Life Sciences and Medicine, Dentistry & Nursing, University of Dundee, Dundee, U.K.

Search for more papers by this author
W.M.C. van Aalderen

W.M.C. van Aalderen

Emma Children's Hospital Amsterdam UMC, University of Amsterdam, Department of Paediatric Respiratory Medicine and Allergy, Amsterdam, the Netherlands

Search for more papers by this author
B. van't Land

B. van't Land

University Medical Centre Utrecht, Wilhelmina Children's Hospital, Department of Paediatric Immunology, Utrecht, the Netherlands

Nutricia Research, Department of Immunology, Utrecht, the Netherlands

Search for more papers by this author
S. Kezic

S. Kezic

Coronel Institute of Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands

Search for more papers by this author
A.B. Sprikkelman

A.B. Sprikkelman

University of Groningen, University Medical Centre Groningen, Beatrix Children's Hospital, Department of Paediatric Pulmonology and Paediatric Allergology, Groningen, the Netherlands

Search for more papers by this author
M.A. Middelkamp-Hup

Corresponding Author

M.A. Middelkamp-Hup

Department of Dermatology, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands

Correspondence

Maritza A. Middelkamp-Hup.

E-mail: [email protected]

Search for more papers by this author
First published: 10 July 2018
Citations: 65
Funding sources This study was supported by an unrestricted grant from the ‘Stichting Steun Emma’ Academic Medical Hospital Amsterdam.
Conflicts of interest B.v.L. leads the strategic alliance between the University Medical Centre Utrecht/Wilhelmina Children's Hospital and Nutricia Research and is employed by Nutricia Research.

Plain language summary available online

Summary

Background

Atopic dermatitis (AD) affects children of all skin types. Most research has focused on light skin types. Studies investigating biomarkers in people with AD with dark skin types are lacking.

Objectives

To explore skin barrier and immune response biomarkers in stratum corneum (SC) tape strips from children with AD with different skin types.

Methods

Tape strips were collected from lesional and nonlesional forearm skin of 53 children with AD and 50 controls. We analysed 28 immunomodulatory mediators, and natural moisturizing factors (NMF) and corneocyte morphology.

Results

Interleukin (IL)-1β, IL-18, C-X-C motif chemokine (CXCL) 8 (CXCL8), C-C motif chemokine ligand (CCL) 22 (CCL22), CCL17, CXCL10 and CCL2 were significantly higher (< 0·05) in lesional AD skin compared with nonlesional AD skin; the opposite trend was seen for IL-1α. CXCL8, CCL2 and CCL17 showed an association with objective SCORing Atopic Dermatitis score. NMF levels showed a gradual decrease from healthy skin to nonlesional and lesional AD skin. This gradual decreasing pattern was observed in skin type II but not in skin type VI. Skin type VI showed higher NMF levels in both nonlesional and lesional AD skin than skin type II. Corneocyte morphology was significantly different in lesional AD skin compared with nonlesional AD and healthy skin.

Conclusions

Minimally invasive tape-stripping is suitable for the determination of many inflammatory mediators and skin barrier biomarkers in children with AD. This study shows differences between children with AD with skin type II and skin type VI in NMF levels, suggesting that some aspects of pathophysiological mechanisms may differ in AD children with light versus dark skin types.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.